Skip to content

S. 641 · 119th Congress (2025–2027)

A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA must publish a list of approved Canadian pharmacies on its website.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is S. 641’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Amy Klobuchar (D-MN)
Cosponsors
8 cosponsors

7 original · 1 later

1 R · 6 D · 1 I

  1. Sen. Tammy Baldwin (D-WI)· Original · Feb 19, 2025
  2. Sen. Chuck Grassley (R-IA)· Original · Feb 19, 2025
  3. Sen. Angus S. King Jr. (I-ME)· Original · Feb 19, 2025
  4. Sen. Jeff Merkley (D-OR)· Original · Feb 19, 2025
  5. Sen. Jeanne Shaheen (D-NH)· Original · Feb 19, 2025
  6. Sen. Peter Welch (D-VT)· Original · Feb 19, 2025
  7. Sen. Sheldon Whitehouse (D-RI)· Original · Feb 19, 2025
  8. Sen. Michael F. Bennet (D-CO)· Later · Nov 19, 2026
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Canada
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Prescription drugs
  • Trade restrictions

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Feb 19, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Safe and Affordable Drugs from Canada Act of 2025

    Display title, Short title · Introduced in Senate

  2. A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.

    Official title · Introduced in Senate